Uniunea Europeană - română - EMA (European Medicines Agency)

pacira limited - citarabină - meningeal neoplasme - agenți antineoplazici - tratamentul intrathecal al meningitei limfomatoase. În majoritatea pacienților, un astfel de tratament va face parte din paliația simptomatică a bolii.

Uniunea Europeană - română - EMA (European Medicines Agency)

gsk vaccines s.r.l. - exterior membrana veziculelor de neisseria meningitidis grup b (tulpina nz 98/254), recombinant neisseria meningitidis grup b fhbp proteină de fuziune, recombinant neisseria meningitidis grup b nada proteine, recombinant neisseria meningitidis grup b nhba proteină de fuziune - meningită, meningococică - vaccinuri meningococice - imunizarea activă împotriva bolilor invazive cauzate de tulpinile serogrup-b ale neisseria meningitidis.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octapharma ab - suedia - proteine plasmatice umane de grup sanguin a,b,, 0 - sol. perf. - 45-70mg/ml - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice

Uniunea Europeană - română - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningită, meningococică - vaccinuri - nimenrix este indicat pentru imunizarea activă a persoanelor de la vârsta de 6 săptămâni împotriva bolilor meningococice invazive cauzate de grupul neisseria meningitidis a, c, w-135 și y.

Uniunea Europeană - română - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

upm din borisov sad - metronidazolum - comprimate - 250 mg

Uniunea Europeană - română - EMA (European Medicines Agency)

warner chilcott uk ltd. - testosteron - disfuncții sexuale, psihologice - hormoni sexuali și modulatori ai sistemului genital, - intrinsa este indicat pentru tratamentul hypoactive dorinta sexuala tulburare (hsdd) în bilateral oophorectomised şi hysterectomised (menopauzei induse chirurgical) femei primesc concomitent estrogen terapie.

Uniunea Europeană - română - EMA (European Medicines Agency)

warner chilcott  deutschland gmbh - testosteron - disfuncții sexuale, psihologice - hormoni sexuali și modulatori ai sistemului genital, - livensa este indicat pentru tratamentul hypoactive dorinta sexuala tulburare (hsdd) în bilateral oophorectomised şi hysterectomised (menopauzei induse chirurgical) femei primesc concomitent estrogen terapie.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pfizer manufacturing austria gmbh - austria - vaccin meningococic polizaharidic de grup c - susp. inj. in seringa preumpluta - 0,5ml - vaccinuri bacteriene vaccinuri meningococice

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

schering-plough central east ag - etonogestrelum + ethinylestradiolum - sistem cu cedare vaginala - 11,7 mg + 2,7 mg